Zhicheng Jin
8PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma.Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin
|Feb 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.Hai-Dong Zhu, Wei-Jun Fan, Chang Zhao
|Jul 28, 2025
Artificial intelligence-driven pathomics in hepatocellular carcinoma: current developments, challenges and perspectives.Wei Ding, Jinxing Zhang, Zhicheng Jin
|Feb 19, 2024
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives.Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong
|Jan 22, 2024
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysis.Jian-Jian Chen, Zhi-Cheng Jin, Biao Luo
|Feb 08, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang
Pageof 2
Frequent Collaborators
4 joint publications
Hai-Dong Zhu
3 joint publications
Bin-Yan Zhong
3 joint publications
Gao-Jun Teng
2 joint publications
Gao-Jun Teng
1 joint publications
Jian-Jian Chen
1 joint publications
Yu-Qing Wang
1 joint publications
Rui Li
1 joint publications
Jian-Jian Chen
1 joint publications
Yong-Yi Zeng
1 joint publications
Yuan-Cheng Wang